Cortisol Might Play Role in Tough-to-Treat Diabetes
By Dennis Thompson HealthDay Reporter
WEDNESDAY, June 26, 2024 -- The stress hormone cortisol appears to play a role in tough-to-treat type 2 diabetes, a new study finds.
About 1 in 4 people (24%) with tough-to-treat type 2 diabetes have elevated cortisol levels, researchers found.
“These results are significant as they highlight a previously underrecognized factor contributing to the barriers when it comes to managing type 2 diabetes,” said lead researcher Dr. John Buse, from the University of North Carolina School of Medicine Diabetes Center and Translational and Clinical Sciences Institute.
Cortisol is produced by the adrenal glands. The hormone affects nearly every organ and tissue in the body, and plays many important roles in daily function, the Cleveland Clinic says.
Among those roles, cortisol helps regulate blood sugar levels, metabolism, blood pressure and inflammation.
Hypercortisolism -- higher-than-normal levels of cortisol -- can cause weight gain, high blood pressure, muscle weakness and mood changes, researchers said. All of these problems can further complicate diabetes management.
For this study, researchers screened over 1,000 diabetics whose hemoglobin A1C levels remained high even though they were receiving multiple diabetes therapies.
The researchers found that 24% of the patients had hypercortisolism.
Elevated cortisol levels were even more common in diabetics taking three or more high blood pressure medications, with about one in three suffering from hypercortisolism.
CT scans revealed adrenal abnormalities in about one-third of these patients, with a quarter having an adrenal tumor, researchers said.
This suggests that surgery to address adrenal gland problems could potentially improve diabetes control, researchers said.
Researchers presented their findings at the American Diabetes Association’s annual meeting in Orlando, Fla. Results presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.
“By identifying hypercortisolism in these patients, we can target treatments more effectively and potentially improve their outcomes,” Buse said in a meeting news release.
The study now has moved into a second phase, with researchers evaluating whether bringing cortisol levels down could make diabetes more manageable.
Sources
- American Diabetes Association, news release, June 24, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Federal Prosecutor Questions Medical Journals Over Alleged Bias
WEDNESDAY, April 23, 2025 — At least three medical journals have received letters from a top federal prosecutor questioning whether they mislead readers or allow political...
Microplastics Could Be Contributing To Clogged Arteries
WEDNESDAY, April 23, 2025 — Microplastics could be contributing to clogged arteries, increasing people’s risk of heart attack or stroke, a new study says. Fatty...
Antibiotics Might Increase Risk of Childhood Asthma, Allergies
WEDNESDAY, April 23, 2025 -- Overuse of antibiotics might increase kids’ risk of developing asthma and allergies, by disrupting their gut bacteria during a crucial stage of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.